Carbiotix AB (publ) (NGM: CRBX)

Market Cap	43.81M
Revenue (ttm)	3.25M
Net Income (ttm)	-16.81M
Shares Out	3.76M
EPS (ttm)	-4.47
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,213
Average Volume	3,946
Open	10.35
Previous Close	10.45
Day's Range	9.30 - 12.95
52-Week Range	3.58 - 32.60
Beta	0.78
RSI	59.92
Earnings Date	Feb 14, 2025

About Carbiotix AB

Carbiotix AB (publ), a biotechnology company develops health testing and microbiome modulators to address a range of chronic and metabolic diseases. Its portfolio includes prebiotic ingredients and diagnostic testing services. The company develops CarbiAXOS, a second-generation prebiotic soluble fiber based on virgin and upcycled natural substrates containing arabinoxylo-oligosaccharides that is customized to meet customer needs to the production of short chain fatty acids or any other effect; and LinkGut, a health test. Carbiotix AB (publ) was...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2014
• Employees: 10
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: CRBX

Financial Performance

In 2023, Carbiotix AB's revenue was 4.29 million, an increase of 37.89% compared to the previous year's 3.11 million. Losses were -13.48 million, 10.0% more than in 2022.